Assembly Biosciences (ASMB) EBT Margin (QoQ) (2017 - 2026)

Assembly Biosciences (ASMB) EBT Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Assembly Biosciences 670.88 Mn 350.52 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 8,170.00
Mar 31, 2026 -19,443.00
Dec 31, 2025 13,725.00
Sep 30, 2025 2,071.00
Jun 30, 2025 5.00
Mar 31, 2025 3,552.00
Dec 31, 2024 -107.00
Sep 30, 2024 -1,450.00
Jun 30, 2024 3,097.00
Mar 31, 2024 -433.00
Dec 31, 2020 -379,148.00
Sep 30, 2020 -2,814.00
Jun 30, 2020 67,161.00
Mar 31, 2020 -6,945.00
Dec 31, 2019 741.00
Sep 30, 2019 999.00
Jun 30, 2019 9,540.00
Mar 31, 2019 -2,657.00
Dec 31, 2018 -16,734.00
Sep 30, 2018 33,147.00